FDA Approves Targeted Drug Combo for Lung Cancer FDA Approves Targeted Drug Combo for Lung Cancer

For the first time, the FDA has approved treatment for metastatic non-small cell lung cancer with BRAF V600E mutation.FDA Approvals (Source: Medscape Medical News Headlines)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2t4p6F1
via IFTTT